ReviewEchocardiography (Mount Kisco, N.Y.)2020
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients.
Review in Echocardiography (Mount Kisco, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 56 citations in OpenAlex.
- Subtle changes on electrocardiogram in severe patients with COVID-19 may be predictors of treatment outcome.Frontiers in artificial intelligence · 2025Article
- The Role of POCUS to Face COVID-19: A Narrative Review.Journal of clinical medicine · 2024Review
- An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.Archives of microbiology & immunology · 2024Article
- Article
- Monthly transthoracic echocardiography in young adults for 6 months following SARS-CoV-2 infection.Physiological reports · 2023Article
- Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physician.Annals of medicine · 2022Review
- Relevance of the post-COVID syndrome within rehabilitation (PoCoRe): study protocol of a multi-centre study with different specialisations.BMC psychology · 2022Article
- Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement.Heart failure reviews · 2022Review
- Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022Article
- COVID-19 pathophysiology and ultrasound imaging: A multiorgan review.Journal of clinical ultrasound : JCU · 2022Review
- Effect Evaluation of Echocardiography on Right Ventricular Function in Patients after the Recovering from Coronavirus Disease 2019.Computational and mathematical methods in medicine · 2022Article
- Utility and diagnostic test properties of pulmonary and cardiovascular point of care ultra-sonography (POCUS) in COVID-19 patients admitted to critical care unit.European journal of radiology open · 2022Article
- The Evolving Role of Echocardiography During the Coronavirus Disease 2019 Pandemic.Heart international · 2022Review
- Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study.Journal of clinical medicine · 2021Article
- Prognostic implications of biventricular strain measurement in COVID-19 patients by speckle-tracking echocardiography.Clinical cardiology · 2021Article
- Late phase of COVID-19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice.ESC heart failure · 2021Article
- Echocardiographic Manifestations in COVID-19: A Review.Heart, lung & circulation · 2021Review
- Article
- Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics.Trends in cardiovascular medicine · 2021Review
- The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19.Frontiers in cardiovascular medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) outbreak is a current global healthcare burden, leading to the life-threatening severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, evidence showed that, even if the prevalence of COVID-19 damage consists in pulmonary lesions and symptoms, it could also affect other organs, such as heart, liver, and spleen. Particularly, some infected patients refer to the emergency department for cardiovascular symptoms, and around 10% of COVID-19 victims had finally developed heart injury. Therefore, the use of echocardiography, according to the safety local protocols and ensuring the use of personal protective equipment, could be useful firstly to discriminate between primary cardiac disease or COVID-19-related myocardial damage, and then for assessing and monitoring COVID-19 cardiovascular complications: acute myocarditis and arrhythmias, acute heart failure, sepsis-induced myocardial impairment, and right ventricular failure derived from treatment with high-pressure mechanical ventilation. The present review aims to enlighten the applications of transthoracic echocardiography for the diagnostic and therapeutic management of myocardial damage in COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.